
Sign up to save your podcasts
Or


🚀 New Breakthrough in Liver Cancer! 🌟
The CheckMate 9DW trial shows that Nivolumab + Ipilimumab significantly improves survival in unresectable #HCC compared to lenvatinib/sorafenib! 🧬💪
#Immunotherapy #CancerResearch #LiverCancer #Oncology 💉
By Dr RR Baliga, MD, MBA5
66 ratings
🚀 New Breakthrough in Liver Cancer! 🌟
The CheckMate 9DW trial shows that Nivolumab + Ipilimumab significantly improves survival in unresectable #HCC compared to lenvatinib/sorafenib! 🧬💪
#Immunotherapy #CancerResearch #LiverCancer #Oncology 💉

900 Listeners

3,378 Listeners

20,475 Listeners